Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer.
Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer. J Clin Invest. 2022 07 15; 132(14).
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Epigenesis, Genetic
Epigenomics
Female
Humans
Neoplasm Recurrence, Local
Ovarian Neoplasms
authors with profiles
John Moroney
Gini Fleming